Teva's $23B Opioid Litigation Deal Faces New Wave Of Attacks
Teva's offer to settle thousands of opioid-crisis lawsuits by donating enough opioid-dependence drugs to satisfy most U.S. demand for 10 years is attracting sharp new criticism from a bipartisan assortment of...To view the full article, register now.
Already a subscriber? Click here to view full article